"At Hematology Oncology Associates, our physicians and specially-trained staff are passionately dedicated to provide comprehensive and patient-centered coordinated care."

During the past decade, Hematology Oncology Associates conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 4 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hematology Oncology Associates" #1 sponsor was "Bristol-Myers Squibb" with 2 trials, followed by "Eli Lilly and Company" with 1 trials sponsored, "Novartis Pharmaceuticals" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "Pharmacyclics LLC." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hematology Oncology Associates" #1 collaborator was "Janssen, LP" with 1 trials as a collaborator and "NSABP Foundation Inc" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hematology Oncology Associates" are "Breast Cancer" (1 trials), "Cancer" (1 trials), "Chronic Lymphocytic Leukemia (CLL)" (1 trials), "Non Small Cell Lung Carcinoma" (1 trials) and "Non-Small Cell Lung Cancer" (1 trials). Many other conditions were trialed in "Hematology Oncology Associates" in a lesser frequency.

Most popular intervention types in "Hematology Oncology Associates" are "Drug" (4 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Carboplatin" (2 trials), "Nivolumab" (2 trials), "Abemaciclib" (1 trials), "Avelumab" (1 trials) and "Best Supportive Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hematology Oncology Associates" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hematology Oncology Associates". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Hematology Oncology Associates, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hematology Oncology Associates, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".